Evasion of inflammasome activation by microbial pathogens.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25642707.
- Also identified by DOI 10.1172/JCI75254 and PMC identifier 4319426.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Activation of the inflammasome occurs in response to infection with a wide array of pathogenic microbes. The inflammasome serves as a platform to activate caspase-1, which results in the subsequent processing and secretion of the proinflammatory cytokines IL-1β and IL-18 and the initiation of an inflammatory cell death pathway termed pyroptosis. Effective inflammasome activation is essential in controlling pathogen replication as well as initiating adaptive immune responses against the offending pathogens. However, a number of pathogens have developed strategies to evade inflammasome activation. In this Review, we discuss these pathogen evasion strategies as well as the potential infectious complications of therapeutic blockade of IL-1 pathways.
Medical subject headings
- Immune Evasion
- Infections
- Inflammasomes
- Interleukin-18
- Interleukin-1beta